Pfizer and BioNTech Push Hard on Omicron-Specific Vaccine While Fending Off Lawsuits
Jul 27, 2022. Pfizer and BioNTech are fending off lawsuits over their mRNA vaccine technology. Pfizer and BioNTech Launch Phase II Trial of Enhanced COVID Vaccine Pfizer and BioNTech initiated a Phase II trial of an enhanced COVID-19 vaccine. This next-generation bivalent vaccine candidate, BNT162b5, is made up of RNAs encoding enhanced prefusion spike proteins…
more “Pfizer and BioNTech Push Hard on Omicron-Specific Vaccine While Fending Off Lawsuits” »